4//SEC Filing
EPIRUS Biopharmaceuticals, Inc. 4
Accession 0001104659-16-101426
CIK 0001135906operating
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:11 PM ET
Size
13.1 KB
Accession
0001104659-16-101426
Insider Transaction Report
Form 4
Shea Thomas A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2016-02-27+3,073→ 33,043 total - Exercise/Conversion
Restricted Stock Units
2016-02-27−1,044→ 0 total→ Common Stock (1,044 underlying) - Exercise/Conversion
Restricted Stock Units
2016-02-27−3,073→ 9,217 total→ Common Stock (3,073 underlying) - Exercise/Conversion
Common Stock
2016-02-27+1,044→ 29,970 total - Tax Payment
Common Stock
2016-02-27$2.80/sh−1,554$4,351→ 31,489 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represented a contingent right to receive a share of the Issuer's common stock, vested in full on February 27, 2016, and had no expiration date.
- [F2]Each RSU represents a contingent right to receive a share of the Issuer's common stock, vests in four (4) substantially equal annual installments beginning on February 27, 2016 provided the Reporting Person remains continuously employed by the Issuer through each vesting date, and has no expiration date.
- [F3]Represents shares of the Issuer's common stock withheld by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portions of the RSUs as reflected in this Form 4.
- [F4]Represents the closing price of shares of the Issuer's common stock on the business day prior to the vesting date for such RSUs.
Documents
Issuer
EPIRUS Biopharmaceuticals, Inc.
CIK 0001135906
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001135906
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 4:11 PM ET
- Size
- 13.1 KB